Published in Brain Res on October 08, 2011
Role of red blood cell lysis and iron in hydrocephalus after intraventricular hemorrhage. J Cereb Blood Flow Metab (2014) 1.00
Autophagy: a double-edged sword for neuronal survival after cerebral ischemia. Neural Regen Res (2014) 0.95
Hydrocephalus after intraventricular hemorrhage: the role of thrombin. J Cereb Blood Flow Metab (2013) 0.92
White Matter Injury After Subarachnoid Hemorrhage: Role of Blood-Brain Barrier Disruption and Matrix Metalloproteinase-9. Stroke (2015) 0.90
Intracerebral Hemorrhage, Oxidative Stress, and Antioxidant Therapy. Oxid Med Cell Longev (2016) 0.84
Macrophage migration inhibitory factor induces vascular leakage via autophagy. Biol Open (2015) 0.82
Intercellular cross-talk in intracerebral hemorrhage. Brain Res (2015) 0.79
TGF-β1 modulates microglial phenotype and promotes recovery after intracerebral hemorrhage. J Clin Invest (2016) 0.79
Progressing haemorrhagic stroke: categories, causes, mechanisms and managements. J Neurol (2014) 0.78
The Potential Therapeutic Effects of Artesunate on Stroke and Other Central Nervous System Diseases. Biomed Res Int (2016) 0.75
LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J (2000) 41.48
Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature (2006) 21.40
Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy (2007) 20.92
Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol (1980) 11.52
Autophagy in cell death: an innocent convict? J Clin Invest (2005) 10.70
The role of autophagy in cancer development and response to therapy. Nat Rev Cancer (2005) 8.18
Mechanisms of brain injury after intracerebral haemorrhage. Lancet Neurol (2006) 6.06
Autophagy is activated by apoptotic signalling in sympathetic neurons: an alternative mechanism of death execution. Mol Cell Neurosci (1999) 3.78
Dual role of 3-methyladenine in modulation of autophagy via different temporal patterns of inhibition on class I and III phosphoinositide 3-kinase. J Biol Chem (2010) 3.45
Autophagy and its possible roles in nervous system diseases, damage and repair. Autophagy (2005) 3.27
Cerebral ischemia-hypoxia induces intravascular coagulation and autophagy. Am J Pathol (2006) 3.18
The molecular mechanism of autophagy. Mol Med (2003) 2.63
Mitochondrial disappearance from cells: a clue to the role of autophagy in programmed cell death and disease? Biochimie (2002) 2.59
Delayed neuronal death in the CA1 pyramidal cell layer of the gerbil hippocampus following transient ischemia is apoptosis. J Neurosci (1995) 1.95
The role of thrombin and thrombin receptors in ischemic, hemorrhagic and traumatic brain injury: deleterious or protective? J Neurochem (2003) 1.69
Attenuation of thrombin-induced brain edema by cerebral thrombin preconditioning. Stroke (1999) 1.49
Autophagy is increased after traumatic brain injury in mice and is partially inhibited by the antioxidant gamma-glutamylcysteinyl ethyl ester. J Cereb Blood Flow Metab (2007) 1.33
Effects of thrombin on neurogenesis after intracerebral hemorrhage. Stroke (2008) 1.15
Autophagy after experimental intracerebral hemorrhage. J Cereb Blood Flow Metab (2007) 1.13
The roles of autophagy in cerebral ischemia. Autophagy (2007) 1.12
Autophagic neuron death in neonatal brain ischemia/hypoxia. Autophagy (2008) 1.10
Activated autophagy pathway in experimental subarachnoid hemorrhage. Brain Res (2009) 0.94
Anion-exchange blocker enhances cytoplasmic vacuole formation and cell death in serum-deprived mouse kidney epithelial cells in mice. Cell Biol Int (2005) 0.90
Thrombin-induced neuronal protection: role of the mitogen activated protein kinase/ribosomal protein S6 kinase pathway. Brain Res (2010) 0.83
Effects of aging on autophagy after experimental intracerebral hemorrhage. Acta Neurochir Suppl (2011) 0.82
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
Mechanisms of brain injury after intracerebral haemorrhage. Lancet Neurol (2006) 6.06
Iron and iron-handling proteins in the brain after intracerebral hemorrhage. Stroke (2003) 2.71
Intracerebral haemorrhage: mechanisms of injury and therapeutic targets. Lancet Neurol (2012) 2.62
Behavioral tests after intracerebral hemorrhage in the rat. Stroke (2002) 2.46
Monocyte chemoattractant protein-1 regulation of blood-brain barrier permeability. J Cereb Blood Flow Metab (2005) 2.45
Brain edema after experimental intracerebral hemorrhage: role of hemoglobin degradation products. J Neurosurg (2002) 2.40
Deferoxamine-induced attenuation of brain edema and neurological deficits in a rat model of intracerebral hemorrhage. J Neurosurg (2004) 2.31
Potential role of MCP-1 in endothelial cell tight junction 'opening': signaling via Rho and Rho kinase. J Cell Sci (2003) 2.21
Absence of the chemokine receptor CCR2 protects against cerebral ischemia/reperfusion injury in mice. Stroke (2007) 2.02
Role of iron in brain injury after intraventricular hemorrhage. Stroke (2010) 1.91
Long-term effects of experimental intracerebral hemorrhage: the role of iron. J Neurosurg (2006) 1.82
Deferoxamine reduces intracerebral hematoma-induced iron accumulation and neuronal death in piglets. Stroke (2009) 1.72
The role of thrombin and thrombin receptors in ischemic, hemorrhagic and traumatic brain injury: deleterious or protective? J Neurochem (2003) 1.69
Brain injury after intracerebral hemorrhage: the role of thrombin and iron. Stroke (2007) 1.68
Effects of deferoxamine on intracerebral hemorrhage-induced brain injury in aged rats. Stroke (2009) 1.65
Pathophysiology of brain edema formation. Neurosurg Clin N Am (2002) 1.50
Effects of the chemokine CCL2 on blood-brain barrier permeability during ischemia-reperfusion injury. J Cereb Blood Flow Metab (2006) 1.49
Hemoglobin and iron handling in brain after subarachnoid hemorrhage and the effect of deferoxamine on early brain injury. J Cereb Blood Flow Metab (2010) 1.46
CCL2 regulates angiogenesis via activation of Ets-1 transcription factor. J Immunol (2006) 1.44
Comparison of experimental rat models of early brain injury after subarachnoid hemorrhage. Neurosurgery (2009) 1.43
Caveolae-mediated internalization of occludin and claudin-5 during CCL2-induced tight junction remodeling in brain endothelial cells. J Biol Chem (2009) 1.42
Protein kinase Calpha-RhoA cross-talk in CCL2-induced alterations in brain endothelial permeability. J Biol Chem (2006) 1.40
Oxidative brain injury from extravasated erythrocytes after intracerebral hemorrhage. Brain Res (2002) 1.39
Brain endothelial cell-cell junctions: how to "open" the blood brain barrier. Curr Neuropharmacol (2008) 1.38
Deferoxamine treatment for intracerebral hemorrhage in aged rats: therapeutic time window and optimal duration. Stroke (2009) 1.36
Intracerebral hemorrhage in mice: model characterization and application for genetically modified mice. J Cereb Blood Flow Metab (2004) 1.35
Tumor necrosis factor-alpha increases in the brain after intracerebral hemorrhage and thrombin stimulation. Neurosurgery (2006) 1.35
Intracerebral hemorrhage: effects of aging on brain edema and neurological deficits. Stroke (2004) 1.35
Subarachnoid hemorrhage-induced hydrocephalus in rats. Stroke (2012) 1.33
A new hippocampal model for examining intracerebral hemorrhage-related neuronal death: effects of deferoxamine on hemoglobin-induced neuronal death. Stroke (2007) 1.31
Peptide and peptide analog transport systems at the blood-CSF barrier. Adv Drug Deliv Rev (2004) 1.31
Hyperbaric oxygen-induced attenuation of hemorrhagic transformation after experimental focal transient cerebral ischemia. Stroke (2007) 1.30
Oxidative DNA injury after experimental intracerebral hemorrhage. Brain Res (2005) 1.30
The deleterious or beneficial effects of different agents in intracerebral hemorrhage: think big, think small, or is hematoma size important? Stroke (2005) 1.24
Myeloid-specific deletion of the mineralocorticoid receptor reduces infarct volume and alters inflammation during cerebral ischemia. Stroke (2010) 1.22
Safety and tolerability of deferoxamine mesylate in patients with acute intracerebral hemorrhage. Stroke (2011) 1.19
Role and relevance of peptide transporter 2 (PEPT2) in the kidney and choroid plexus: in vivo studies with glycylsarcosine in wild-type and PEPT2 knockout mice. J Pharmacol Exp Ther (2005) 1.19
Impact of genetic knockout of PEPT2 on cefadroxil pharmacokinetics, renal tubular reabsorption, and brain penetration in mice. Drug Metab Dispos (2007) 1.19
Edaravone attenuates brain edema and neurologic deficits in a rat model of acute intracerebral hemorrhage. Stroke (2007) 1.16
Effect of sustained-mild and transient-severe hyperglycemia on ischemia-induced blood-brain barrier opening. J Cereb Blood Flow Metab (2007) 1.15
Effects of thrombin on neurogenesis after intracerebral hemorrhage. Stroke (2008) 1.15
Autophagy after experimental intracerebral hemorrhage. J Cereb Blood Flow Metab (2007) 1.13
Immunolocalization of the proton-coupled oligopeptide transporter PEPT2 in developing rat brain. Mol Pharm (2005) 1.12
Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson's disease. Brain (2010) 1.12
Mechanisms of hydrocephalus after neonatal and adult intraventricular hemorrhage. Transl Stroke Res (2012) 1.11
Peptide transporter 2 (PEPT2) expression in brain protects against 5-aminolevulinic acid neurotoxicity. J Neurochem (2007) 1.11
Deferoxamine reduces neuronal death and hematoma lysis after intracerebral hemorrhage in aged rats. Transl Stroke Res (2013) 1.10
Targeted disruption of the PEPT2 gene markedly reduces dipeptide uptake in choroid plexus. J Biol Chem (2002) 1.10
Intracerebral hirudin injection attenuates ischemic damage and neurologic deficits without altering local cerebral blood flow. J Cereb Blood Flow Metab (2004) 1.10